轮匝肌切除术联合睫毛外翻褥式缝合对先天性下睑内翻的矫治效果

Correction of congenital entropion of the lower eyelid by orbicularis oculi muscle resection combined with mattress suture with eyelash everted

摘要:

目的 探究轮匝肌切除术联合睫毛外翻褥式缝合对先天性下睑内翻的矫治效果。方法 选取2019年1月—2022年1月南通大学附属医院眼科收治的82例先天性下睑内翻患儿，采用随机数字表法分为切除术组和缝线组，每组41例，切除术组采用轮匝肌切除术联合睫毛外翻褥式缝合治疗，缝线组采用传统缝线法治疗。术后2个月，比较两组的临床疗效、角膜散光值、最佳矫正视力及泪膜破裂时间。结果 切除术组治疗有效率为98.75%，高于缝线组90.00%（P <0.05）。切除术组治疗前后柱镜度数、泪膜破裂时间的差值均高于缝线组（P <0.05）；两组治疗前后轴位、最佳矫正视力的差值比较，差异无统计学意义（P >0.05）。结论 轮匝肌切除术联合睫毛外翻褥式缝合应用于先天性下睑内翻患儿的治疗中，更有助于提升临床疗效，保护视力且安全性良好。

Abstract:

Objective To investigate the efficacy of orbicularis oculi muscle resection combined with mattress suture with eyelash everted for the correction of congenital entropion of the lower eyelid.Methods From January 2019 to January 2022, eighty-two children with congenital lower eyelid entropion admitted to the Affiliated Hospital of Nantong University were selected. They were divided into the resection group and the suture group by the random number method, with 41 cases in each group. The resection group was treated with orbicularis oculi muscle resection combined with mattress suture with eyelash everted. The suture group was treated with traditional suture method. Two months after the operation, the clinical efficacy, corneal astigmatism, best corrected visual acuity and tear film break-up time of the two groups were compared.Results The effective rate of treatment in the resection group was 98.75%, which was higher than 90.00% in the suture group (P < 0.05). The differences in the cylindrical power, best corrected visual acuity, and tear film break-up time before and after treatment in the resection group were higher than those in the suture group (P < 0.05). There was no statistically significant difference in the axial length of the eye between the two groups before and after treatment (P > 0.05).Conclusions For treating children with congenital lower eyelid entropion, orbicularis oculi muscle resection combined with mattress suture with eyelash everted is conducive to improving the clinical efficacy and protecting the vision with a good safety profile.